Back to search

Cornell University

Engineering A Rapid Point-Of-Care Diagnostic Platform Utilizing Tethered Enzyme Technology For Time-Sensitive Pathologies

Abstract

dc:description.abstract

The primary advances in creating a point-of-care testing (PoCT) diagnostic platform involve miniaturizing assays based on recognition of biomarker antigens with antibodies. This approach has inherent issues with time-sensitive pathologies because of the inherently slow speed of antibodyantigen interactions. Such an obstacle can be overcome through use of faster enzymatic reactions. In this work, we focused on creating an enzymatic based PoCT diagnostic platform suitable for timesensitive pathologies, in particular addressing stroke. We hypothesize that by immobilizing enzymes to nanoparticles (NP) the enzymes will be stabilized and confined to a smaller volume, therefore increasing the efficiency of sequential enzymatic reactions needed to detect biomarkers at physiological and pathological levels in human serum and transduce that detection into a luminescent signal. Development of this platform involved several key steps, including immobilizing functional enzymes on inorganic surfaces and developing microfluidic systems with microliter-volume reactions. Because the use of immobilized enzymes in hybrid organic-inorganic devices is in a nascent stage of development, it is also essential to work out fundamental principles of how the inorganic scaffolds might affect the activities of the tethered enzymes. Through biomimicry of the sperm flagellum, enzymes were designed to include a His-tag to bind with Ni-NTA groups on an inorganic surface in a precise orientation. This approach yielded higher specific activity than did attachment of the same enzymes through adsorption or chemically-specific binding (e.g. amine-carboxyl) techniques. While the orientation had dramatic impacts on the enzyme function, the surface size/curvature to which it is bound also influenced the enzyme function. Prior literature on this relationship was largely anecdotal. To identify generalizable truths regarding the iii effects of the surface size and curvature on enzyme function, we used three enzymes, each representing a different class of enzyme, at maximal enzyme loading and in monolayers on gold NPs ranging in size from 5 to 50 nm in diameter. We found that larger NPs had increased enzyme multilayer formations and decreased kcat and specific activity by 2.8 to 8.3 fold, depending on the enzyme. Contrary to other reports and suggesting an advantage for oriented immobilization, we did not see effects of size on the same enzymes when tethered in monolayers. Tethering to NPs has immediate application in medical diagnosis of time-sensitive pathologies due to enzymes' rapid catalysis versus slow antibody interactions. Neuron specific enolase (NSE) is a biomarker for stroke, which we detected through the sequential reaction of tethered luciferase (Luc) and pyruvate kinase (PK), yielding a luminescent signal proportional to the concentration of enolase in our samples. In both rat stroke models and human patient samples, we found this diagnostic platform gave accurate results in 10 minutes compared to typical 4 hour ELISA tests, yet maintained a high correlation with the results from ELISA. In addition to NSE, we also utilized a tethered enzymatic reaction to detect phosphoglycerate mutase (PGM) at concentrations as low as 0.6 ng/ml. PGM is being investigated as a biomarker for stroke and myocardial infarction. Lastly, we moved this technology into a PoCT platform by localizing them in microfluidic chip devices and stabilizing reactions at microliter volumes. This was accomplished with pluronic F108 as the cryogenic protectant during lyophilization of 10 [MICRO SIGN]l reactions. We produced the microchannel devices using SU-8 lithography and included a positive, negative and test channel. We demonstrated that these microfluidic cards with enzymes tethered to NPs in the reaction wells could detect enolase at physiological and pathological levels. Building on these advancements, we can now pursue a plethora of biomarkers to detect time-sensitive pathologies. iv

Degree

thesis:*
Name thesis:degree_name
Ph. D., Biomedical Engineering
Level thesis:degree_level
Doctor of Philosophy
Discipline thesis:degree_discipline
Biomedical Engineering
Grantor
Cornell University
Year dc:date.issued
2015

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Lata, James
Chair dc:contributor.chair
  • Travis,Alexander J.
Committee members dc:contributor.committeemember
  • Erickson,David
  • Jin,Moonsoo

Subjects

dc:subject × 3

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Dc Identifier Bibid
9255224

Chain of custody

source
Harvested from
Cornell University
Base URL
ecommons.cornell.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Lata, James. Engineering A Rapid Point-Of-Care Diagnostic Platform Utilizing Tethered Enzyme Technology For Time-Sensitive Pathologies. Doctor of Philosophy thesis, Cornell University, 2015. https://hdl.handle.net/1813/40952